Respiratory Syncytial Virus (RSV) is the second largest cause of respiratory illness in adults second to the Flu, however there are no specific prevention options. Older adults who are infected with RSV may be susceptible to more severe illnesses such as pneumonia.

This trial involves an investigational RSV vaccine coadministered with a seasonal flu vaccine. If eligible, you would be required to attend 3 visits at one of our clinics over 2 months, and also report events at home via an eDiary.